STOCKHOLDERS EQUITY (DEFICIT) AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($) |
1 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 16, 2025 |
May 21, 2025 |
Dec. 23, 2024 |
Sep. 30, 2024 |
Sep. 27, 2024 |
May 23, 2024 |
Jan. 18, 2022 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Jan. 31, 2025 |
Jun. 22, 2024 |
Jan. 26, 2023 |
Sep. 08, 2021 |
Jun. 30, 2021 |
Oct. 14, 2020 |
Apr. 09, 2013 |
|
| Common stock, shares authorized | 100,000,000 | 100,000,000 | 6,666,667 | 200,000,000 | 50,000,000 | 20,000,000 | 100,000 | |||||||||||
| Common stock, shares par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||||||||||
| Shares available for future stock compensation grants | 1,071 | |||||||||||||||||
| Stock Compensation Plan [Member] | ||||||||||||||||||
| Stock issued during period, shares, restricted stock award | 116 | |||||||||||||||||
| recognized stock-based compensation expense | $ 5,016 | |||||||||||||||||
| Initial Public Offering [Member] | ||||||||||||||||||
| Stock option plan | 100 | |||||||||||||||||
| Inducement Letter Agreement [Member] | ||||||||||||||||||
| Exercise price | $ 927 | $ 1,575 | $ 4,050 | |||||||||||||||
| Warrants issued to purchase common stock | 8,985 | 4,443 | 740 | |||||||||||||||
| Inducement letter agreement, Description | the Company entered into an inducement letter agreement (the “October 2025 Inducement”) with an institutional investor and existing holder of (i) warrants to purchase 5 shares of the Company’s common stock issued on May 9, 2022 with an initial exercise price of $75,000 (the “May 2022 Warrants”), (ii) warrants to purchase 2 shares of Common Stock issued on September 8, 2023 with an initial exercise price of $270,000 (the “September 2023 Warrants”), (iii) Class A warrants to purchase 24 shares of Common Stock and Class B warrants to purchase 236 shares of Common Stock issued on May 23, 2024 with initial exercise prices of $16,763 (the “May 2024 Warrants”), and (iv) warrants to purchase 4,443 shares of Common Stock issued on May 21, 2025 with an initial exercise price of $1,575 (the “May 2025 Warrants” and collectively with the May 2022 Warrants, September 2023 Warrants, and May 2024 Warrants, the “Existing Warrants”). The Existing Warrants were all immediately exercisable upon issuance. Pursuant to the October 2025 Inducement, the Holder agreed to exercise the Existing Warrants for cash at a reduced exercise price of $927 per share in consideration for the Company’s agreement to issue new unregistered five-year | the Company entered into an inducement letter agreement (the “May 2025 Inducement”) with the Holder of September Class A Warrants to purchase 740 shares of the Company’s common stock, (ii) December 2024 Class A Warrants to purchase 740 shares of Common Stock and (iii) December 2024 Class B Warrants to purchase 740 shares of Common Stock; and collectively, the (“Existing Warrants”). The Existing Warrants had original exercise prices of $4,050 per share and became exercisable immediately following issuance. Pursuant to the May 2025 Inducement, the Holder agreed to exercise the Existing Warrants for cash at a reduced exercise price of $1,575 per share in consideration for the Company’s agreement to issue new unregistered five-year warrants | the Company entered into an inducement letter agreement (the “December 2024 Inducement”) with an institutional investor and existing holder (the “Holder”) of September Class B Warrants to purchase 740 shares of the Company’s common stock. Pursuant to the December 2024 Inducement, the Holder agreed to exercise the September Class B Warrants for cash at the exercise price of $4,050 per share in consideration for the Company’s agreement to issue: (i) new unregistered five-year warrants to purchase up to an aggregate of 740 shares of common stock at an exercise price of $90 per share (the “December 2024 Class A Warrants”) | |||||||||||||||
| Proceeds from the Inducement Letter Agreement | $ 4,164,000 | $ 3,498,000 | $ 3,841,000 | |||||||||||||||
| Underwriting and other fees | 280,000 | 237,000 | $ 177,308 | |||||||||||||||
| Deemed dividend | $ 6,685,000 | $ 9,833,000 | $ 3,873,000 | |||||||||||||||
| September 2024 Public Offering [Member] | ||||||||||||||||||
| Exercise price | $ 4,050 | $ 4,050 | ||||||||||||||||
| Offering and reimbursement and legal fees | $ 80,000 | |||||||||||||||||
| Gross proceeds from issue of warrant under placement agreement net | $ 4,795,158 | |||||||||||||||||
| Gross proceeds from issue of warrant under placement agreement | 5,552,484 | |||||||||||||||||
| Paid underwriting fees | $ 757,326 | |||||||||||||||||
| Issued of warrants to purchase | 70 | |||||||||||||||||
| Description of best-efforts public offering | the Company closed a best-efforts public offering (the “September Offering”) of (i) 377 common units, each consisting of one share of common stock, one Class A warrant (the “September Class A Warrant”) to purchase one share of common stock and one Class B warrant (the “September Class B Warrant,” together with the September Class A Warrants, the “September Warrants”) to purchase one share of common stock at a purchase price of $4,050 per unit; and (ii) 1,019 pre-funded units, each consisting of one pre-funded warrant to purchase one share of common stock (“September Pre-Funded Warrant”), one September Class A Warrant and one September Class B Warrant at a purchase price of $3,938 per unit | |||||||||||||||||
| 2024 Public offering [Member] | ||||||||||||||||||
| Exercise price | $ 25,425 | $ 25,425 | $ 16,763 | |||||||||||||||
| Offering and reimbursement and legal fees | $ 80,000 | |||||||||||||||||
| Gross proceeds from issue of warrant under placement agreement net | 5,498,252 | |||||||||||||||||
| Gross proceeds from issue of warrant under placement agreement | 5,998,120 | |||||||||||||||||
| Paid underwriting fees | $ 499,868 | |||||||||||||||||
| Issued of warrants to purchase | 118 | |||||||||||||||||
| Description of best-efforts public offering | the Company completed a best-efforts public offering (the “May Offering”) of (i) 5,416 common units, each consisting of one share of common stock, one Class A warrant (“May Class A Warrant”) to purchase one share of common stock and one Class B warrant (“May Class B Warrant,” together with the May Class A Warrants, the “May Warrants”) to purchase one share of common stock at a purchase price of $25,470 per unit; and (ii) 19 pre-funded units, each consisting of one pre-funded warrant to purchase one share of common stock (“May Pre-Funded Warrant”), one May Class A Warrant and one May Class B Warrant at a purchase price of $25,335 per unit | |||||||||||||||||
| 2024 Equity Distribution Agreement [Member] | Series A Convertible Preferred Stocks [Member] | ||||||||||||||||||
| Gross proceeds | $ 2,428,392 | |||||||||||||||||
| Warrants issued to purchase common stock | 1,769 | |||||||||||||||||
| Paid commissions | $ 88,000 | |||||||||||||||||
| 2025 Equity Distribution Agreement [Member] | Series A Convertible Preferred Stocks [Member] | ||||||||||||||||||
| Aggregate offering price | $ 30,000 | |||||||||||||||||
| Commission rate | 3.50% | |||||||||||||||||
| Equity Distribution Agreement [Member] | ||||||||||||||||||
| Aggregate offering price, shares | 2,516,000 | |||||||||||||||||